Population-based evaluation of treatment patterns and survival of localized prostate cancer (CaP) patients with high prostate-specific antigen (PSA)

被引：0
|
作者：
Ye, Fan
Hendrix, Laura H.
Waddle, Mark Raymond
Chen, Ronald C.
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Univ N Carolina, Sch Med, Chapel Hill, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e16008
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16008
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Population-based screening using prostate-specific antigen testing reduced prostate cancer mortality
    Hugosson, J.
    Carlsson, S.
    Aus, G.
    Hoffman, Richard M.
    ANNALS OF INTERNAL MEDICINE, 2010, 153 (12)
  • [32] Prostate-specific antigen (PSA): A tumor marker in the diagnosis of prostate cancer
    Ohlendorf D.
    Wanke E.M.
    Braun M.
    Oremek G.M.
    Groneberg D.A.
    Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 2017, 67 (4) : 221 - 223
  • [33] Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer
    Tobias Nordström
    Olof Akre
    Markus Aly
    Henrik Grönberg
    Martin Eklund
    Prostate Cancer and Prostatic Diseases, 2018, 21 : 57 - 63
  • [34] Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
    Duvedi, Priya
    Singh, Harjinder
    Bedi, Gurdeep Kaur
    Kaur, Maninder
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (05) : BC01 - BC03
  • [35] EVALUATION OF PROSTATE-SPECIFIC ANTIGEN IN PROSTATE-CANCER
    PONSANICET, D
    RAMAIOLI, A
    NAMER, M
    KREBS, BP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 : S71 - S74
  • [36] Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era
    Gilliland, FD
    Hunt, WC
    Key, CR
    UROLOGY, 1996, 48 (01) : 67 - 71
  • [37] Assessment of Prostate-Specific Antigen (PSA) Kinetics in Prediction of Prostate Cancer on Prostate Biopsy
    Shinmei, S.
    Inoue, S.
    Ohkuchi, T.
    Yasukawa, A.
    UROLOGY, 2012, 80 (03) : S282 - S282
  • [38] PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF RADIOTHERAPY RESPONSE AND PATTERNS OF FAILURE IN LOCALIZED PROSTATE-CANCER
    RITTER, MA
    MESSING, EM
    SHANAHAN, TG
    POTTS, S
    CHAPPELL, RJ
    KINSELLA, TJ
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) : 1208 - 1217
  • [39] Prostate cancer treatment using a modified proaerolysin that requires activation by prostate-specific antigen (PSA).
    Rosen, M
    Gady, A
    Buckley, T
    Denmeade, SR
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3679S - 3679S
  • [40] Is prostate-specific antigen a surrogate for survival in advanced prostate cancer?
    Collette, L
    Burzykowski, T
    Carroll, K
    Newling, D
    Morris, T
    Schroder, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 394S - 394S
12345